JaneAnneLeopoldMD
Cardiology • Boston, MAInterventional Cardiology
Associate Professor of Medicine, Brigham and Women's Hospital
Dr. Leopold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Brigham & Womens Hospital
Boston, MA 02115Phone+1 617-732-5500Fax+1 617-525-4830
Education & Training
Boston University Medical CenterFellowship, Cardiovascular Disease, 1994 - 1998
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1994
Boston University School of MedicineClass of 1991
Certifications & Licensure
MA State Medical License 1993 - 2026
RI State Medical License 2018 - 2020- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- My Research Legacy Pilot Study Start of enrollment: 2016 Nov 11
Publications & Presentations
PubMed
- 6 citationsIntegrative Omics to Characterize and Classify Pulmonary Vascular Disease.Jane A. Leopold, Anna R. Hemnes
Clinics in Chest Medicine. 2021-01-12 - 33 citationsClinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.Anna R Hemnes, Jane A Leopold, Milena K Radeva, Gerald J Beck, Aiden Abidov
Journal of the American College of Cardiology. 2022-08-16 - 138 citationsAldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arter...Bradley A. Maron, Ying-Yi Zhang, Kevin P. White, Stephen Y. Chan, Diane E. Handy
Circulation. 2012-08-21
Press Mentions
Findings from STELLAR Phase III Trial Presented at ACC23 Report Novel First-in-Class Medication Shows Promise in Treating Rare Heart Lung ConditionMarch 6th, 2023- Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVISeptember 18th, 2022
- Mitral Valve Repair Devices Go Head-to-Head, and the Top Spot Belongs To...September 17th, 2022
- Join now to see all
Grant Support
- Aldosterone, Autophagy, And Arterial StiffnessNational Heart, Lung, And Blood Institute2010–2011
- Sickle Cell Disease G6PDNational Heart, Lung, And Blood Institute2008–2011
- Aldosterone, G6pd, And Vascular Endothelial FunctionNational Heart, Lung, And Blood Institute2005–2009
- G6PD And Oxidant Stress In Vascular Smooth Muscle CellsNational Heart, Lung, And Blood Institute2000–2004
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
